Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas

Journal of Investigative Dermatology

Volumn 112, Issue 3, 1999, Pages 317-321

  McGregor, Jane M ^a   Crook, Tim ^a   Fraser Andrews, Elizabeth A ^b   Rozycka, Magdalena ^a   Crossland, Susan ^a   Brooks, Louise ^c   Whittaker, Sean J ^b,d,e  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Mycosis fungoides; Non Hodgkin's lymphoma

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; INTERFERON; PREDNISONE; PROTEIN P53; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; DNA DAMAGE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUVA; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN LYMPHOMA; SKIN TUMOR; TUMOR SUPPRESSOR GENE; ULTRAVIOLET B RADIATION;

EID: 0033052124     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00507.x     Document Type: Article

References (38)

1. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M: Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 310:1491-1495, 1995
2. Bates S, Vousden KH: p53 in signalling checkpoint arrest or apoptosis. Curr Opinion Genet Dev 6:12-18, 1996
3. Bentham G: Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. Br Med J 312(7039):1128-1131, 1996
4. Beylot-Barry M, Vergier B, DeMascarel A, Beylot C, Merlio J. P53 oncoprotein expression in cutaneous lymphoproliferations. Arch Dermatol 131:1019-1024, 1995
5. Boni R, Davis-Daneshear A, Burg G, Fucjs D, Wood GS. No detection of HTLV-1 proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol 134:282-284, 1996
6. Brash D, Rudolph J, Simon J, Lin A, et al: A role for sunlight in skin cancer. UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991
7. Campbell C, Quinn AG, Ro YS, Angus B, Rees JL. P53 mutations are common and early events that precede tumour invasion in squamous cell neoplasia of the skin. J Infest Dermatol 100(6):746-748, 1993
8. Cartwright R, McNally R, Staines A: The increasing incidence of non-Hodgkin's lymphoma (NHL). the possible role of sunlight. Leukaemia Lymphoma 14:387-394, 1994
9. Dumaz N, Stary A, Soussi T, Daya-Grosjean L, Sarasin A. Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutat Res 307:375-386, 1994
10. Freedman DM, Zahm SH, Dosemeci M: Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma. composite (threefold) case control study. Br Med J 314:1451-1455, 1997
11. Freeman SE, Hacham H, Gange RW, Maytum DJ, Sutherland JC, Sutherland BM. Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with UV light. Proc Natl Acad Sci USA 86:5605-5609, 1989
12. Hall P, Rosendahl I, Mattsson A, Einhorn S. Non-Hodgkin's lymphoma and skin malignancies - shared aetiology? Int J Cancer 62 (5):519-522, 1995
13. Hartge P, Devessa SS, Graumen D, Fears TR, Fraumeni JF Jr. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst 88:298-300, 1996
14. Hayashi K, Yandell D. How sensitive is PCR-SSCP? Hum Mutat 2:338-346, 1993
15. Hutchinson F. Induction of tandem base change mutations. Mutat Res 309:11-15, 1994
16. Isaacson PG, Norton AJ: Cutaneous lymphoma. In. Extranodal Lymphomas London: Churchill Livingstone, 131-191, 1994
17. Lauritzen AF, Vejlsgaard GL, Hou-Jensen K, Ralfkier E. P53 protein expression in cutaneous T-cell lymphoma. Br J Dermatol 133:32-36, 1995
18. Li G, Chooback L, Wolfe JT, Rook AH, Felix CA, Lessin SR, Salhany KE: Overexpression of p53 protein in cutaneous T-cell lymphoma. relationship to large cell transformation and disease progression. J Invest Dermatol 110:767-770, 1998
19. Marks DI, Vonderheid EC, Kurz BW, et al. Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndrome. Br J Haematol 92:890-899, 1996
20. McGregor JM, Dublin EA, Levison DA, MacDonald DM, Smith NP, Whittaker S. P53 immunoreactivity is uncommon in primary cutaneous lymphoma. Br J Dermatol 132:353-358, 1995
21. Nataraj AJ, Trent JC, Ananthaswamy HN. p53 gene mutations and photocarcinogenesis. Photochem, Photobiol 62(2):218-230, 1995
22. Neri A, Fracchiolla NS, Roscetti E, et al. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 8:3160-3172, 1995
23. Newcomb EW. P53 gene mutations in lymphoid diseases and their possible relevance to drug resistance. Leukemia Lymphoma 17:211-221, 1994
24. Newton R. Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin's lymphomas. Br Med J 314:1483-1484, 1997
25. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-709, 1989
26. Pancake B, Zucker-Francklin D, Coutavas E. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotrophic virus-associated disease. J Clin Invest 95:547-554, 1995
27. Reid TM, Loeb LA: Tandem double CC.TT mutations are produced by reactive oxygen species. Proc Natl Acad Sci USA 90(9):3904-3907, 1993
28. Robert C, Muel B, Benoit A, Dubertret L, Sarasin A, Stary A. Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. J Invest Dermatol 106:721-728, 1996
29. Rosenstein BS, Mitchell DL. Action spectra for the induction of pyrimidine (6-4) pyrimidone photoproducts and cyclobutane pyrimidine dimers in normal human skin fibroblasts. Photochem Photobiol 45:775-780, 1987
30. Salhany KE, Cousar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous T cell lymphoma to large cell lymphoma. Am J Pathol 132:265-277, 1988
31. Tornaletti S, Pfeiffer GP. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 263(5152):1436-1438, 1994
32. Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature 355:209-210, 1992
33. Weinstock MA, Horm JW. Mycosis fungoides in the United States - increasing incidence and descriptive epidemiology. JAMA 260:42-46, 1988
34. Whittaker SJ, Luzzatto L. HTLV-1 provirus and mycosis fungoides. Science 259:1470, 1993
35. Whittaker SJ, Smith NP, Russell-Jones R, Luzzatto L. Analysis of beta, gamma and delta T-cell receptor genes in mycosis fungoides and Sézary syndrome. Cancer 68:1572-1582, 1991
36. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas. a proposal from the cutaneous lymphoma study group of the European organisation for research and treatment of cancer. Blood 90:354-371, 1997
37. Wilson WH, Teruya-Feldstein J, Fest T, Harris C, Steinberg SM, Jaffe ES, Raffeld M. Relationship of p53, bcl-2, and tumour proliferation to clinical drug resistance in non-Hodgkin's lymphomas. Blood 89:601-609, 1997
38. Wood GS, Salevekar A, Schaffer J, et al: Evidence against a role for human T-cell lymphotropic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol 107.301-307, 1996